Open Access

Anti‑inflammatory effects of Fagopyrum cymosum administered as a potential drug for ulcerative colitis

  • Authors:
    • Fei Ge
    • Shilin Zhu
    • Lina Liu
    • Jing Yan
    • Yu Ji
    • Zhiguang Sun
  • View Affiliations

  • Published online on: September 20, 2017     https://doi.org/10.3892/etm.2017.5153
  • Pages: 4745-4754
  • Copyright: © Ge et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Fagopyrum cymosum (Trev.) Meisn (Fag), which belongs to the Polygonaceae family, has been widely used to treat inflammatory diseases. Previous studies have revealed that Fag components exhibit anti‑inflammatory activities; however, their potential use in treating inflammatory bowel disease (IBD) has not been explored. In the present study, mice with 2,4,6‑trinitrobenzenesulfonic acid (TNBS)‑induced colitis were used as a model of IBD. Fag extract was orally administered for 3 days following the induction of colitis and the conventional drug, salicylazosulfapyridine (SASP), was used as a control. The results revealed that Fag significantly ameliorated TNBS‑induced body weight loss and colonic shortening in mice (P<0.05). Furthermore, Fag suppressed levels of proinflammatory cytokines and reduced macrophage infiltration into colonic tissues (P<0.05). To further verify the anti‑inflammatory effects of Fag at the molecular level, a murine macrophage cell line, Raw264.7, was used. Nuclear translocation of nuclear factor (NF)‑κB p65 and the phosphorylation of inhibitor of NF‑κB (IκB) were assessed using western blotting. The results demonstrated that Fag inhibited the production of proinflammatory cytokines via inhibiting NF‑κB p65 nuclear translocation and IκB phosphorylation (P<0.05). Furthermore, the clinical study results revealed that Fag had significantly fewer side effects (P<0.05) and served as a better anti‑inflammatory drug for ulcerative colitis compared with SASP.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 14 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ge F, Zhu S, Liu L, Yan J, Ji Y and Sun Z: Anti‑inflammatory effects of Fagopyrum cymosum administered as a potential drug for ulcerative colitis. Exp Ther Med 14: 4745-4754, 2017
APA
Ge, F., Zhu, S., Liu, L., Yan, J., Ji, Y., & Sun, Z. (2017). Anti‑inflammatory effects of Fagopyrum cymosum administered as a potential drug for ulcerative colitis. Experimental and Therapeutic Medicine, 14, 4745-4754. https://doi.org/10.3892/etm.2017.5153
MLA
Ge, F., Zhu, S., Liu, L., Yan, J., Ji, Y., Sun, Z."Anti‑inflammatory effects of Fagopyrum cymosum administered as a potential drug for ulcerative colitis". Experimental and Therapeutic Medicine 14.5 (2017): 4745-4754.
Chicago
Ge, F., Zhu, S., Liu, L., Yan, J., Ji, Y., Sun, Z."Anti‑inflammatory effects of Fagopyrum cymosum administered as a potential drug for ulcerative colitis". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4745-4754. https://doi.org/10.3892/etm.2017.5153